Literature DB >> 1834366

Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine.

M B Patel1, J M Stewart, A V Loud, P Anversa, J Wang, L Fiegel, T H Hintze.   

Abstract

BACKGROUND: We have previously shown that chronic elevation of plasma norepinephrine leads to a functional independent increase in left ventricular weight. The goals of the present study were to determine quantitatively the component of the myocardium that accounted for the observed structural changes and to determine the function of the hypertrophied myocardium. METHODS AND
RESULTS: Mongrel dogs were chronically instrumented for measurement of arterial and left ventricular pressures, left ventricular internal diameter, and left ventricular wall thickness. Subcutaneous osmotic pumps were implanted to release norepinephrine continuously for 28 days. Hemodynamics were measured with dogs in the quietly resting state and during infusions of isoproterenol at 0.1 and 0.5 micrograms/kg/min before and on days 14 and 28 during the infusion of norepinephrine. The hemodynamic response to 10 micrograms/kg phenylephrine, given as a bolus, was also assessed before norepinephrine and 28 days during the infusion of norepinephrine, and the end-systolic pressure-diameter or wall-stress-diameter relations were calculated. On day 28, hearts were arrested in diastole and perfusion fixed in situ. Tissue samples were prepared for electron microscopy and morphometry. Hemodynamic studies showed that isoproterenol (0.5 micrograms/kg/min) reduced mean arterial pressure (MAP) to the same point on each experimental day, and the increases in indexes of contractility were reduced during norepinephrine infusion. Left ventricular dP/dtmax increased 131 +/- 24% on control day, only 67 +/- 20% on day 14, and 55 +/- 18% on day 28. Similar changes were observed in dP/dt/DP40 and dP/dt/end-diastolic circumference. However, Emax, the slope of the end-systolic pressure-diameter or wall stress diameter relations, was unchanged, suggesting that inotropic state was not altered. Morphometric studies showed that the cross-sectional area of myocytes increased by 55%, but myocyte and capillary densities decreased by 34% and 29%, respectively (p less than 0.05) in dogs with high norepinephrine levels. There were no differences in volume fractions of myocytes, capillary lumen, or interstitium or capillary-to-myocyte ratio.
CONCLUSIONS: The myocardium of dogs with high norepinephrine levels shows reduced inotropic response to beta-adrenergic stimulation despite the increases in left ventricular mass and left ventricular wall thickness, which are a result of growth of the cardiac myocytes and characteristic of concentric hypertrophy. These data suggest that chronic adrenergic stimulation of the heart reduces the beta-receptor coupling to the contractile response without importantly compromising left ventricular function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834366     DOI: 10.1161/01.cir.84.5.2091

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.

Authors:  Ewa Soltysinska; Stefanie Thiele; Søren Peter Olesen; Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2011-08-03       Impact factor: 3.657

2.  Frequent periodic leg movement during sleep is associated with left ventricular hypertrophy and adverse cardiovascular outcomes.

Authors:  Mahek Mirza; Win-Kuang Shen; Aamir Sofi; Ahad Jahangir; Naoyo Mori; A Jamil Tajik; Arshad Jahangir
Journal:  J Am Soc Echocardiogr       Date:  2013-04-24       Impact factor: 5.251

Review 3.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

Review 4.  Sympathetic mechanisms, organ damage, and antihypertensive treatment.

Authors:  Guido Grassi; Gino Seravalle; Raffaella Dell'Oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

5.  Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.

Authors:  Katrin Wenzel; Gerd Wallukat; Fatimunnisa Qadri; Norbert Hubner; Herbert Schulz; Oliver Hummel; Florian Herse; Arnd Heuser; Robert Fischer; Harald Heidecke; Friedrich C Luft; Dominik N Muller; Rainer Dietz; Ralf Dechend
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

Review 6.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

Review 7.  Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Authors:  Brian C Jensen; Timothy D OʼConnell; Paul C Simpson
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

8.  Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease.

Authors:  Jeanie Park; Robert H Lyles; Susan Bauer-Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-14       Impact factor: 3.619

Review 9.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

10.  Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.

Authors:  Jeanie Park
Journal:  Cardiol Res Pract       Date:  2012-08-07       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.